Increased levels of ethane, a non-invasive, quantitative, direct marker of n-3 lipid peroxidation, in the breath of patients with schizophrenia by Puri, Basant K et al.
MEETING ABSTRACT Open Access
Increased levels of ethane, a non-invasive,
quantitative, direct marker of n-3 lipid
peroxidation, in the breath of patients
with schizophrenia
Basant K Puri
1*, Brian M Ross
2, Ian H Treasaden
3
From 1
st International Congress on Neurobiology and Clinical Psychopharmacology and
European Psychiatric Association Conference on Treatment Guidance
Thessaloniki, Greece. 19-22 November 2009
Background
This study directly assessed whether there was a change
in the level of exhaled ethane, which provides a non-
invasive, quantitative, direct measure of n-3 lipid per-
oxidation, in the breath of patients with schizophrenia.
Materials and methods
Samples of alveolar air were obtained from 20 subjects
with schizophrenia and 23 age- and sex-matched healthy
control subjects. The air samples were analyzed for
ethane using mass spectrometry.
Results
The mean level of ethane in the schizophrenia sample
(5.15 (S.E. 0.56) ppb) was significantly higher than that
of the healthy controls (2.63 (S.E. 0.31) ppb; p < 0.0005).
A further sub-analysis showed that nicotine dependence
was unlikely to be the cause of this difference.
Conclusions
These results suggest that the measurement of exhaled
ethane levels may offer a non-invasive direct marker of
increased n-3 lipid peroxidation in schizophrenia.
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